Evidence map›Paper›PMID 34787440›Full record

ArticleMicrobiology spectrum2021

Comparison of sCIM and Other Phenotypic Detection Methods for Carbapenemase-Producing

Takuya Hosoda, Yohei Doi, Masahiro Suzuki

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Investigation of carbapenem-hydrolysingJournal of medical microbiology · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Takuya HosodaDepartment of Clinical Laboratory, Fujita Health University Okazaki Medical Center, Okazaki, Japan.
Yohei DoiDepartment of Microbiology, Fujita Health University School of Medicine, Toyoake, Japan.ORCID 0000-0002-9620-2525
Masahiro SuzukiDepartment of Microbiology, Fujita Health University School of Medicine, Toyoake, Japan.ORCID 0000-0003-4550-3499
Fujita Health University · JP

Funding

Colistin-resistant Acinetobacter baumanniiR01AI104895 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI, ERNST, ROBERT K · 2014 to 2024
$4.2M
Mechanisms of cefiderocol resistanceR21AI151362 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2020 to 2021
$420k
NIAID NIH HHS R01 AI104895NIAID NIH HHS R21 AI151362
6 · The paper itself

Abstract

Rapid detection and reporting of carbapenemase-producing

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsEnterobacteriaceaeEnterobacteriaceae InfectionsEscherichia coliHumansKlebsiella pneumoniaeLaboratories, ClinicalSensitivity and SpecificitySerratia marcescensAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemscarbapenemase-producing EnterobacteralesmCIMsCIM

Identifiers

PMID34787440
PMCPMC8597650
OpenAlexW3212289671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.